Leukapheresis market to surpass USD 174 million by 2027, attaining a CAGR of 7.4%

2022-06-18 08:06:43 UTC | Healthcare & Pharmaceuticals
Leukapheresis market to surpass USD 174 million by 2027, attaining a CAGR of 7.4%
Leukapheresis is a laboratory procedure in which white blood cells are separated from a sample of blood. It is the first step in a treatment called CAR (chimeric antigen receptor) T-cell therapy. The global leukapheresis market is expected to increase by USD 61 million, at a compound annual growth rate (CAGR) of 7.4% from 2021 to 2027, according to the latest edition of the Global Leukapheresis Market Report.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global leukapheresis market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the leukapheresis industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, end user, and region. The global market for leukapheresis can be segmented by product: leukapheresis devices, leukapheresis disposables. The leukapheresis disposables segment was the largest contributor to the global leukapheresis market in 2020. Leukapheresis market is further segmented by application: research, therapies. Based on end user, the leukapheresis market is segmented into: blood centers, hospitals & infusion centers, enterprises, academic & research institutes. On the basis of region, the leukapheresis market also can be divided into: Asia Pacific, Europe, North America, Middle East and Africa (MEA), South America.

By product:
- leukapheresis devices
- leukapheresis disposables

By application:
- research
- therapies

By end user:
- blood centers
- hospitals & infusion centers
- enterprises
- academic & research institutes

By region:
- Asia Pacific
- Europe
- North America
- Middle East and Africa (MEA)
- South America

The report also provides analysis of the key companies of the industry and their detailed company profiles including AllCells Corporation, Asahi Kasei Corporation, BioIVT LLC, Fresenius SE & Co. KGaA, Haemonetics Corporation, HemaCare Corporation (Charles River Laboratories International, Inc.), Macopharma, STEMCELL Technologies Inc., StemExpress, LLC, Terumo Corporation, among others.

Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Read Full Report : https://gen-cons.com/store/global-leukapheresis-market

Scope of the Report
- To analyze and forecast the market size of the global leukapheresis market.
- To classify and forecast the global leukapheresis market based on product, application, end user, region.
- To identify drivers and challenges for the global leukapheresis market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global leukapheresis market.
- To identify and analyze the profile of leading players operating in the global leukapheresis market.

Why Choose This Report
- Gain a reliable outlook of the global leukapheresis market forecasts from 2021 to 2027 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.